The lymphocytic choriomeningitis virus (LCMV) system constitutes one of the most widely used models for the study of infectious disease and the regulation of virus-specific T cell immunity. However, with respect to the activity of costimulatory and associated regulatory pathways, LCMV-specific T cell responses have long been regarded as relatively independent and thus distinct from the regulation of T cell immunity directed against many other viral pathogens. Here, we have reevaluated the contribution of CD28-CD80/86 costimulation in the LCMV system by use of CD80/86-deficient mice, and our results demonstrate that a disruption of CD28-CD80/86 signaling compromises the magnitude, phenotype, and/or functionality of LCMVspecific CD8 ؉ and/or CD4 ؉ T cell populations in all stages of the T cell response. Notably, a profound inhibition of secondary T cell immunity in LCMV-immune CD80/86-deficient mice emerged as a composite of both defective memory T cell development and a specific requirement for CD80 but not CD86 in the recall response, while a related experimental scenario of CD28-dependent yet CD80/86-independent secondary CD8 ؉ T cell immunity suggests the existence of a CD28 ligand other than CD80/ 86. Furthermore, we provide evidence that regulatory T cells (T REG s), the homeostasis of which is altered in CD80/86 ؊/؊ mice, contribute to restrained LCMV-specific CD8 ؉ T cell responses in the presence of CD80/86. Our observations can therefore provide a more coherent perspective on CD28-CD80/86 costimulation in antiviral T cell immunity that positions the LCMV system within a shared context of multiple defects that virus-specific T cells acquire in the absence of CD28-CD80/86 costimulation.T he generation of specific T cell immunity is governed by multiple determinants that shape the proliferative expansion and functional maturation of effector T cells (T E ) as well as their subsequent differentiation into memory T cells (T M ). Conceptualization of these processes permits the straightforward demarcation of T cell receptor (TCR)-peptide/major histocompatibility complex (MHC) interactions ("signal 1"), yet the simple notion of a defined "costimulus" required for the optimization of specific T cell responses, historically referred to as "signal 2," has been eroded by the realization that a multiplicity of diverse receptor-ligand interactions between T cells and antigen-presenting cells (APCs), soluble factors (e.g., cytokines), and specific temporospatial constraints operate in concert to control the eventual magnitude as well as the molecular, phenotypic, and functional properties of responding T E populations. Thus, it is the integration of signals derived from a large complex of stimulatory and inhibitory interactions that permits activated T cells the translation of minimal kinetic alterations into profound modifications of the ensuing T cell response (26,84). Insofar as these interactions produce a kinetic, quantitative, and/or qualitative enhancement of specific T cell immunity, individual components with...